CD8A and neoplasm: In this study, we provide the first evidence that inhibition of ATM activation increases tumor cell surface antigen presentation by up-regulating the expression of MHC-I molecules, so that more CD8+ T cells can recognize and attack tumor cells, and regulate the function of other immune cells by secreting cytokines, and enhance the tumor immunity “heat” of TNBC.